Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Andrews

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Veterinary Microbiology|November 17, 2009
Identification of Brucella abortus genes in elk (Cervus elaphus) using in vivo-induced antigen technology (IVIAT) reveals novel markers of infectionJ E Lowry, L Goodridge, G Vernati, et al.
Molecular Pharmaceutics|February 1, 2019
Fixed Dose Combination Formulations: Multilayered Platforms Designed for the Management of Cardiovascular DiseaseG P Andrews, S Li, A Almajaan, et al.
Vaccine|January 24, 2007
Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccineS F Little, B E Ivins, W M Webster, et al.
Vaccine|July 13, 2004
Development of an in vitro-based potency assay for anthrax vaccineS F Little, W M Webster, B E Ivins, et al.
Infection and Immunity|January 1, 1989
Characterization of CS4 and CS6 antigenic components of PCF8775, a putative colonization factor complex from enterotoxigenic Escherichia coli E8775M K Wolf, G P Andrews, B D Tall, et al.
Vaccine|December 13, 2003
Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccineS F Little, B E Ivins, P F Fellows, et al.
AAPS Pharmscitech|September 9, 2021
Solvent-Assisted Hot Melt Extrusion of a Thermally Labile, High Melting Point CompoundC Lagan, J E Huckle, J M Katz, et al.
Vaccine|July 31, 1998
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccineD G Heath, G W Anderson, J M Mauro, et al.
The American Journal of Tropical Medicine and Hygiene|April 1, 1997
Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestisG W Anderson, P L Worsham, C R Bolt, et al.
Infection and Immunity|March 20, 1999
Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in miceG E Benner, G P Andrews, W R Byrne, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Veterinary Microbiology|November 17, 2009
Identification of Brucella abortus genes in elk (Cervus elaphus) using in vivo-induced antigen technology (IVIAT) reveals novel markers of infectionJ E Lowry, L Goodridge, G Vernati, et al.
Molecular Pharmaceutics|February 1, 2019
Fixed Dose Combination Formulations: Multilayered Platforms Designed for the Management of Cardiovascular DiseaseG P Andrews, S Li, A Almajaan, et al.
Vaccine|January 24, 2007
Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccineS F Little, B E Ivins, W M Webster, et al.
Vaccine|July 13, 2004
Development of an in vitro-based potency assay for anthrax vaccineS F Little, W M Webster, B E Ivins, et al.
Infection and Immunity|January 1, 1989
Characterization of CS4 and CS6 antigenic components of PCF8775, a putative colonization factor complex from enterotoxigenic Escherichia coli E8775M K Wolf, G P Andrews, B D Tall, et al.
Vaccine|December 13, 2003
Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccineS F Little, B E Ivins, P F Fellows, et al.
AAPS Pharmscitech|September 9, 2021
Solvent-Assisted Hot Melt Extrusion of a Thermally Labile, High Melting Point CompoundC Lagan, J E Huckle, J M Katz, et al.
Vaccine|July 31, 1998
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccineD G Heath, G W Anderson, J M Mauro, et al.
The American Journal of Tropical Medicine and Hygiene|April 1, 1997
Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestisG W Anderson, P L Worsham, C R Bolt, et al.
Infection and Immunity|March 20, 1999
Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in miceG E Benner, G P Andrews, W R Byrne, et al.
Pageof 4